Overview of the Pharmacological Management of Osteoporosis in Postmenopausal Women

Shulamite, N. Sherly; Malavika, B. Pragna; Swami, P. Aravinda

doi:10.9734/jpri/2021/v33i41a32321

Cited by 3 publications

(4 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For many individuals, particularly postmenopausal women with osteoporosis, recommendations include sunlight and supplements in order to ensure enough vitamin D, rather than relying on food. 10 There's a significant lack of adherence in methods of mitigating bone loss, indicating the need for continued education. Bone loss prevention and management begins with lifestyle changes, including diet and exercise.…”

Section: Literature Reviewmentioning

confidence: 99%

Evidence-based education to mitigate osteoporosis through diet and exercise

Bazaar,

Travers,

Karl

et al. 2024

Nursing Made Incredibly Easy!

View full text Add to dashboard Cite

show abstract

Section: Literature Reviewmentioning

confidence: 99%

Evidence-based education to mitigate osteoporosis through diet and exercise

Bazaar,

Travers,

Karl

et al. 2024

Nursing Made Incredibly Easy!

View full text Add to dashboard Cite

show abstract

“…Of the postmenopausal women involved in the study where 31% were non-osteoporotic and, 69% were osteoporotic. 15…”

Section: Sample Sizementioning

confidence: 99%

“…The weight in kilograms was divided by the square of the height measured in meters, as per the previous study, 2.6%, 18.4%, 75%, and 4% were obese, overweight, normal, and underweight. 15…”

Section: Assessment Of Bmimentioning

confidence: 99%

Knowledge, attitude, and practice assessment regarding osteoporosis among post-menopausal women attending an urban health centre in south India

Nelapati

2022

Int J Community Med Public Health

View full text Add to dashboard Cite

Background: This study aimed to assess the awareness of osteoporosis in postmenopausal women. Objective was to evaluate knowledge, attitude, and practices about osteoporosis and its correlation among postmenopausal women.Methods: Cross-sectional study was carried out to assess the state of awareness in consecutive postmenopausal women using a validated questionnaire- osteoporosis knowledge assessment tool (OKAT).Results: A total of 300 postmenopausal women were enrolled in this study. In spite of being aware of the consequences of osteoporosis, in most subjects there was a generalized lack of awareness concerning available treatment options and risk factors. We have observed about 40% of had poor awareness about osteoporosis.Conclusions: This study showed an evident deficit in awareness of osteoporosis in postmenopausal women and there’s a need to emphasize educating and aware, women regarding the consequences of osteoporosis.

show abstract

“…VK2 supplementation is required in patients taking anticoagulant medications, and people suffering from fat malabsorption or liver diseases. VK2 supplementation is widely used for the treatment of osteopenia and osteoporosis [10].…”

Section: Introduction 1backgroundmentioning

confidence: 99%

A Case Control Study Evaluating the Relationship between Vitamin K2 Serum Level and Periodontitis

Olszewska-Czyz,

Firkova

2023

Healthcare

View full text Add to dashboard Cite

Background and Aim: Vitamin K2 (VK2) is an essential co-factor for bone metabolism. There is still very little data regarding possible VK2 relation to periodontitis. This study aimed to investigate any potential link between VK2 serum level and the severity of periodontitis in comparison to a control group of healthy individuals. The trial was performed on 100 patients among whom 50 were diagnosed with periodontitis. The patients underwent full clinical periodontal and radiological examination. The VK2 serum level was assessed using the ELISA kit (Gla-type osteocalcin EIA Kit, Takara, Kusatsu). Patients with periodontitis had mean serum levels of VK2 significantly lower (0.27 ± 0.06 nmol/L; p < 0.001) than the control group (0.43 ± 0.09 nmol/L; p < 0.001) regardless of the patient’s age or sex. The VK2 serum level decreased with the severity of periodontitis with the lowest level in stage IV of the disease (0.19 ± 0.01 nmol/L; p < 0.001). Also, a significant drop was noticed between the grades of periodontitis. Individuals with localized forms of the disease had significantly lower VK2 levels (0.26 ± 0.006 nmol/L; p < 0.001) in comparison to subjects with generalized periodontitis (0.30 ± 0.01 nmol/L; p < 0.001). The VK2 serum levels were also associated with most of the clinical parameters such as bleeding on probing (−0.805, 95% CI: −0.894 to −0.654, p < 0.001), attachment loss (−0.752, 95% CI: −0.862 to −0.574, p < 0.001), and bone loss (−0.656, 95% CI: −0.801 to −0.439, p < 0.001). In the present study, the VK2 serum level was correlated to periodontitis, and its severity, complexity, extension, and grade. The range of VK2 was decreasing together with the worsening of all clinical parameters of periodontitis.

show abstract

Overview of the Pharmacological Management of Osteoporosis in Postmenopausal Women

Cited by 3 publications

References 7 publications

Evidence-based education to mitigate osteoporosis through diet and exercise

Evidence-based education to mitigate osteoporosis through diet and exercise

Knowledge, attitude, and practice assessment regarding osteoporosis among post-menopausal women attending an urban health centre in south India

A Case Control Study Evaluating the Relationship between Vitamin K2 Serum Level and Periodontitis

Contact Info

Product

Resources

About